H.R. 6996 · 117th Congress

Accelerating Access for Patients Act of 2022

Stage
In committee
Introduced
2022-03-08
Latest action
2022-03-09 · Referred to the Subcommittee on Health.

Summary

Accelerating Access for Patients Act of 2022

This bill modifies requirements relating to accelerated approval of drugs for serious or life-threatening diseases or conditions, including by requiring guidance from the Food and Drug Administration and coordinated plans with product sponsors on appropriate postapproval studies.